TPWA
TNGX icon

Twin Peaks Wealth Advisors’s Tango Therapeutics TNGX Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$42 – 2016
2026
Q1 		$42 Buy
+2
New +$28 ﹤0.01% 2312
2025
Q3 		– Sell
-1
Closed -$7 – 1946
2025
Q2 		$7 Buy
+1
New +$2 ﹤0.01% 2271

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Twin Peaks Wealth Advisors's TNGX Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Tango Therapeutics (TNGX) in Q2 2026, closing a stake of 2 shares — an estimated $42 sold.

Twin Peaks Wealth Advisors first reported a position in TNGX in Q2 2025 and held it in 2 quarters. The position peaked at $42 in Q1 2026. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Tango Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 2 Tango Therapeutics shares in Q2 2026, an estimated $42.
  • Twin Peaks Wealth Advisors first reported a position in Tango Therapeutics in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Tango Therapeutics position peaked at $42 in Q1 2026.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.